MindWalk Holdings (HYFT) FCF Margin (2023 - 2026)
MindWalk Holdings (HYFT) posted quarterly FCF Margin of 0.08% for Q2 2026, down 4.0% year-over-year from 0.08% in Q2 2025, and up 99.89% quarter-over-quarter from 70.73% in Q1 2026.
MindWalk Holdings (HYFT) FCF Margin (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported FCF Margin for 4 consecutive years, with 0.08% the latest figure, recorded in Q2 2026.
- In Q2 2026, FCF Margin fell 4.0% year-over-year to 0.08%; the TTM figure through Apr 2026 stood at 0.16% (down 8.0% YoY), while the FY2026 annual figure was 82.66%, down 1482.0% from the prior year.
- FCF Margin rose to 0.08% in Q2 2026 per HYFT's latest filing, from 70.73% in the prior quarter.
- Across five years, FCF Margin topped out at 41.75% in Q2 2024 and bottomed at 124.36% in Q3 2025.
- Historically, FCF Margin has averaged 31.82% across 4 years, with a median of 13.29% in 2023.
- Annual changes were most pronounced in 2024 — FCF Margin jumped 12647 bps — and 2025, when it sank 12430 bps.
- MindWalk Holdings' FCF Margin stood at 4.57% in 2023, then sank by 1880 bps to 81.34% in 2024, then jumped by 100 bps to 0.07% in 2025, then fell by 14 bps to 0.08% in 2026.
- Business Quant data shows HYFT's FCF Margin at 0.08% in Q2 2026, 70.73% in Q1 2026, and 0.07% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -18,629.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -0.08% |
| Jan 31, 2026 | -70.73% |
| Oct 31, 2025 | -0.07% |
| Jul 31, 2025 | -124.36% |
| Apr 30, 2025 | -0.03% |
| Jan 31, 2025 | -39.99% |
| Oct 31, 2024 | -81.34% |
| Jul 31, 2024 | -0.06% |
| Apr 30, 2024 | 41.75% |
| Jan 31, 2024 | -19.24% |
| Oct 31, 2023 | 4.57% |
| Jul 31, 2023 | -7.33% |
| Apr 30, 2023 | -84.72% |
| Jan 31, 2023 | -63.82% |